International Patent: ANTIBODY OR ANTIBODY FRAGMENT THEREOF SPECIFICALLY BINDING TO TSPAN1, AND THERAPEUTIC, PROPHYLACTIC, OR DIAGNOSTIC USE THEREOF

GENEVA, Oct. 5 -- PORTRAI INC. filed a patent application (KR2025/004416) for “ANTIBODY OR ANTIBODY FRAGMENT THEREOF SPECIFICALLY BINDING TO TSPAN1, AND THERAPEUTIC, PROPHYLACTIC, OR DIAGNOSTIC USE THEREOF”. With publication no. WO/2026/205624, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....